Lower risk of ischemic stroke among patients with chronic kidney disease using chinese herbal medicine as add-on therapy: A real-world nationwide cohort study.

Front Pharmacol · 2022 · PMC9403506 · PMID 36034816

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Moreover, in the stratification analysis of the medication, CKD patients receiving the CHM in combination with conventional medications showed a trend of reduced risk of IS compared with those receiving conventional medications only ( Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.